Diagnose Better. Treat Smarter.

Tailoring genomic information into therapeutic decisions

The Future of MSI Evaluation MSIcare is a revolutionary tool designed to simplify and enhance the detection of microsatellite instability (MSI). For example, by leveraging advanced AI algorithms and the latest breakthroughs in bioinformatics, MSIcare delivers unparalleled diagnostic accuracy, making it an essential solution for oncology professionals. Key Benefits of MSIcare: Advanced AI Algorithms: Cutting-edge artificial intelligence technology enables deep analysis of genetic data, thus significantly enhancing diagnostic precision. Comprehensive Pan-Cancer Analysis: Optimized for various cancer types—including colorectal, endometrial, gastric, and more—MSIcare broadens its clinical applicability across multiple oncological disciplines. In addition, this versatility ensures that the tool remains valuable in diverse diagnostic scenarios. Seamless Lab Integration: Designed to work directly with data from FASTQ and BAM files, MSIcare operates independently of sequencing platforms, thereby streamlining lab workflows and reducing turnaround times. Personalized Medicine: The tool offers actionable insights for predicting treatment responses, therefore supporting a tailored approach to patient care that enhances treatment efficacy. Moreover, embracing MSIcare opens new horizons in the diagnosis and treatment of cancer. By integrating state-of-the-art technology with machine learning, our tool not only identifies microsatellite instability but also improves overall diagnostic efficiency. Consequently, this paves the way for a shift toward precision oncology and truly personalized medicine. For more insights and updates, follow us on LinkedIn at msinsight (opens in a new tab).

Our Reason

Why is MSI Detection Important?

NEW CANCER DIAGNOSIS*

1 M

POSSIBLE MSI CANCER CASES*

1 M

CONFIRMED MSI CANCER DIAGNOSIS*

1 %

*per year worldwide

About Us

MSInsight is empowering precision medicine in oncology by revealing actionable information on Microsatellite Instability – MSI – through genomic analysis.

Unite a team of experts in genomics, bioinformatics, and clinical research to drive innovation.

Uphold transparency, excellence, and patient-centered values in everything we do.

Advance diagnostics in oncology and hereditary diseases with cutting-edge technology.

Scientific Foundation

Providing state-of-the-art diagnostic solutions and supporting therapeutic decision-making, MSInsight specializes in MSI analysis for cancer patients.

Technology

We are leveraging the power of genomic data from next-generation sequencing (NGS) with the best-in-class bioinformatic algorithms and AI solutions.

Just upload your genomic data and we provide you the right information

Discover how our cutting-edge solution, MSIcare, is transforming the way MSI is detected and monitored in various types of solid cancers.

News

Improving diagnosis for better care.

Home – MSInsight – Microsatellite Instability (MSI) new medicine